CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
CASI Pharmaceuticals beat estimated earnings by 33.33%, reporting an EPS of $-0.06 versus an estimate of $-0.09.
Revenue was up $3.33 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 1.9% increase in the share price the next day.
Here's a look at CASI Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.06 | -0.05 | -0.07 | -0.06 |
| EPS Actual | -0.04 | -0.07 | -0.05 | -0.11 |
| Revenue Estimate | 9.07M | 7.54M | 6.02M | 5.05M |
| Revenue Actual | 9.16M | 8.11M | 7.16M | 5.74M |
To track all earnings releases for CASI Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
